IndustryPayments
Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

TERESA MICHELLE GILLILAND

Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family

NPI
1255799540
CMS profile
11178365
Location
SALISBURY, MD

General Payments · PY2021–2024

$4,205.87

  • Reported across 175 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$1,326.51

53 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

Related groups: Family MD All categories

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $1,326.51 53

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Acerta Pharma LLC $436.41 17
NOVARTIS PHARMACEUTICALS CORPORATION $166.52 8
GENZYME CORPORATION $162.12 5
Lilly USA, LLC $143.91 2
Amgen Inc. $79.39 4
Takeda Pharmaceuticals U.S.A., Inc. $73.28 3
BioCryst US Sales Co., LLC $55.79 3
Pharming Healthcare, Inc. $53.23 3
CSL Behring $52.50 3
Genentech USA, Inc. $44.05 2
GlaxoSmithKline, LLC. $35.19 2
Blueprint Medicines Corporation $24.12 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2021 $567.06 27
PY2022 $1,052.20 41
PY2023 $1,260.10 54
PY2024 $1,326.51 53

Payment records · PY2024 (53)

Sorted by paying entity, then date · as published by CMS

Program year 2024 202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Amgen Inc. $17.63 01/24/2024 Food and Beverage Undisputed 01/23/2026 1117261063 CMS
Amgen Inc. $18.69 07/24/2024 Food and Beverage Undisputed 01/23/2026 1117261067 CMS
Amgen Inc. $22.96 10/16/2024 Food and Beverage Undisputed 01/23/2026 1117261069 CMS
Amgen Inc. $20.11 12/11/2024 Food and Beverage Undisputed 01/23/2026 1117261071 CMS
AstraZeneca Pharmaceuticals LP $13.27 01/10/2024 Food and Beverage Undisputed 01/23/2026 1105671355 CMS
AstraZeneca Pharmaceuticals LP $18.76 01/16/2024 Food and Beverage Undisputed 01/23/2026 1104614824 CMS
AstraZeneca Pharmaceuticals LP $12.91 02/07/2024 Food and Beverage Undisputed 01/23/2026 1104261755 CMS
AstraZeneca Pharmaceuticals LP $22.04 02/08/2024 Food and Beverage Undisputed 01/23/2026 1105291360 CMS
AstraZeneca Pharmaceuticals LP $85.94 02/23/2024 Food and Beverage Undisputed 01/23/2026 1104775936 CMS
AstraZeneca Pharmaceuticals LP $17.97 03/13/2024 Food and Beverage Undisputed 01/23/2026 1104200641 CMS
AstraZeneca Pharmaceuticals LP $14.54 04/09/2024 Food and Beverage Undisputed 01/23/2026 1104764044 CMS
AstraZeneca Pharmaceuticals LP $19.36 04/17/2024 Food and Beverage Undisputed 01/23/2026 1105318703 CMS
AstraZeneca Pharmaceuticals LP $26.18 05/08/2024 Food and Beverage Undisputed 01/23/2026 1104361011 CMS
AstraZeneca Pharmaceuticals LP $17.73 06/04/2024 Food and Beverage Undisputed 01/23/2026 1105425916 CMS
AstraZeneca Pharmaceuticals LP $88.68 07/10/2024 Food and Beverage Undisputed 01/23/2026 1104395809 CMS
AstraZeneca Pharmaceuticals LP $15.64 07/16/2024 Food and Beverage Undisputed 01/23/2026 1105813195 CMS
AstraZeneca Pharmaceuticals LP $16.19 07/22/2024 Food and Beverage Undisputed 01/23/2026 1104370959 CMS
AstraZeneca Pharmaceuticals LP $22.78 09/09/2024 Food and Beverage Undisputed 01/23/2026 1105332070 CMS
AstraZeneca Pharmaceuticals LP $14.00 10/14/2024 Food and Beverage Undisputed 01/23/2026 1105572325 CMS
AstraZeneca Pharmaceuticals LP $16.06 12/05/2024 Food and Beverage Undisputed 01/23/2026 1105640578 CMS
AstraZeneca Pharmaceuticals LP $14.36 12/17/2024 Food and Beverage Undisputed 01/23/2026 1105790640 CMS
BioCryst US Sales Co., LLC $18.70 02/27/2024 Food and Beverage Undisputed 01/23/2026 1117475492 CMS
BioCryst US Sales Co., LLC $14.37 08/19/2024 Food and Beverage Undisputed 01/23/2026 1117477106 CMS
BioCryst US Sales Co., LLC $22.72 11/04/2024 Food and Beverage Undisputed 01/23/2026 1117478786 CMS
Blueprint Medicines Corporation $24.12 04/10/2024 Food and Beverage Undisputed 01/23/2026 1147444017 CMS
CSL Behring $18.12 04/18/2024 Food and Beverage Undisputed 01/23/2026 1134663939 CMS
CSL Behring $19.07 10/21/2024 Food and Beverage Undisputed 01/23/2026 1134663995 CMS
CSL Behring $15.31 11/18/2024 Food and Beverage Undisputed 01/23/2026 1134664007 CMS
Genentech USA, Inc. $19.92 02/28/2024 Food and Beverage Undisputed 01/23/2026 1133191822 CMS
Genentech USA, Inc. $24.13 05/01/2024 Food and Beverage Undisputed 01/23/2026 1133191825 CMS
GENZYME CORPORATION $12.40 03/12/2024 Food and Beverage Undisputed 01/23/2026 1139900830 CMS
GENZYME CORPORATION $18.99 05/29/2024 Food and Beverage Undisputed 01/23/2026 1139900868 CMS
GENZYME CORPORATION $68.88 08/20/2024 Food and Beverage Undisputed 01/23/2026 1139900904 CMS
GENZYME CORPORATION $29.45 08/21/2024 Food and Beverage Undisputed 01/23/2026 1139900912 CMS
GENZYME CORPORATION $32.40 10/09/2024 Food and Beverage Undisputed 01/23/2026 1139900934 CMS
GlaxoSmithKline, LLC. $15.24 05/21/2024 Food and Beverage Undisputed 01/23/2026 1116720636 CMS
GlaxoSmithKline, LLC. $19.95 11/06/2024 Food and Beverage Undisputed 01/23/2026 1116258237 CMS
Lilly USA, LLC $18.91 11/11/2024 Food and Beverage Undisputed 01/23/2026 1135968528 CMS
Lilly USA, LLC $125.00 11/19/2024 Food and Beverage Undisputed 01/23/2026 1135895463 CMS
Novartis Pharmaceuticals Corporation $17.24 01/29/2024 Food and Beverage Undisputed 01/23/2026 1086810525 CMS
Novartis Pharmaceuticals Corporation $19.43 02/21/2024 Food and Beverage Undisputed 01/23/2026 1086810529 CMS
Novartis Pharmaceuticals Corporation $22.28 05/20/2024 Food and Beverage Undisputed 01/23/2026 1086810531 CMS
Novartis Pharmaceuticals Corporation $24.16 06/18/2024 Food and Beverage Undisputed 01/23/2026 1086810533 CMS
Novartis Pharmaceuticals Corporation $21.00 07/17/2024 Food and Beverage Undisputed 01/23/2026 1086810537 CMS
Novartis Pharmaceuticals Corporation $23.71 08/12/2024 Food and Beverage Undisputed 01/23/2026 1086810539 CMS
Novartis Pharmaceuticals Corporation $19.00 10/07/2024 Food and Beverage Undisputed 01/23/2026 1086810565 CMS
Novartis Pharmaceuticals Corporation $19.70 11/20/2024 Food and Beverage Undisputed 01/23/2026 1086810567 CMS
Pharming Healthcare, Inc. $24.60 01/18/2024 Food and Beverage Undisputed 01/23/2026 1132176571 CMS
Pharming Healthcare, Inc. $13.72 08/05/2024 Food and Beverage Undisputed 01/23/2026 1132176580 CMS
Pharming Healthcare, Inc. $14.91 09/23/2024 Food and Beverage Undisputed 01/23/2026 1132176588 CMS
Takeda Pharmaceuticals U.S.A., Inc. $28.63 03/06/2024 Food and Beverage Undisputed 01/23/2026 1137753638 CMS
Takeda Pharmaceuticals U.S.A., Inc. $24.97 06/04/2024 Food and Beverage Undisputed 01/23/2026 1137753640 CMS
Takeda Pharmaceuticals U.S.A., Inc. $19.68 08/28/2024 Food and Beverage Undisputed 01/23/2026 1137753642 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.